FUNDUS CAMERA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Fundus Camera Market Size and Forecast: 2026-2033

The Fundus Camera Market is anticipated to grow at a CAGR of 7.2% with USD 32.7 Bn in 2026 and is expected to reach USD 46.8 Bn in 2033. The rising prevalence of eye disorders such as diabetic retinopathy and glaucoma, along with an increasing geriatric population, and greater awareness of early diagnosis. Globally, over 103 million people were affected by diabetic retinopathy in 2020, a number projected to rise significantly with the growing diabetic population.

Key Takeaways

• Mydriatic fundus cameras are expected to hold the largest market share of 38.8% in 2026, driven by the rising prevalence of retinal diseases, with over 103 million people globally affected by diabetic retinopathy, increasing demand for detailed retinal imaging.
• Stationary/tabletop systems are projected to account for 53.7% of the market in 2026, supported by superior image resolution and diagnostic accuracy, with studies showing over 90% diagnostic reliability in detecting retinal disorders using high-end tabletop systems.
• Hospitals are expected to lead with a 34.4% share in 2026, due to high patient inflow, with global hospital outpatient visits exceeding 5 billion annually, boosting diagnostic equipment usage.
• By Region, North America is projected to dominate with 39.2% share in 2026, supported by advanced healthcare infrastructure, where over 65% of adults undergo routine eye screenings, driving strong adoption of fundus imaging systems.

Current Events and Their Impact on the Fundus Camera Market

Segmental Insights

Stationary/Tabletop holds the Largest Market Share

Stationary/Tabletop expected to hold largest market share of 53.7% in 2026. Strong demand for high-resolution and consistent retinal imaging in clinical settings drives the stationary or tabletop fundus camera segment. These systems deliver superior image quality, stability, and reproducibility, which enable clinicians to make accurate diagnoses and track long-term disease progression effectively. Hospitals and specialty eye clinics prefer tabletop devices because they integrate easily with advanced diagnostic workflows and multimodal imaging platforms. The rising prevalence of macular degenration support their adoption for complex case management and detailed ophthalmic evaluations. The Macular Degeneration Partnership estimates around 200,000 new cases of age-related macular degeneration (AMD) are diagnosed each year. In addition, the BrightFocus Foundation reports that approximately 11 million people in the United States are affected by AMD.

Why is Mydriatic Fundus Acquiring the Largest Market Share?

Mydriatic Fundus hold the largest market share of 38.8% in 2026 owing to the Strong demand from hospitals & specialty clinics. Growth is supported by the rising prevalence of retinal diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. Globally, over 76 million people are living with glaucoma, a number projected to reach nearly 112 million by 2040, making it a leading cause of irreversible blindness. In addition, glaucoma accounts for approximately 12% of global blindness cases, highlighting the need for early and detailed retinal imaging. These systems offer superior image resolution and wide-field visualization, enabling accurate diagnosis, disease monitoring, and surgical planning.

Which End User segment dominates the market?

Hospitals acquired the prominent market share of 34.4% in 2026 owing to its Growth of hospital-based screening programs. Hospitals drive the fundus camera market because they manage large patient volumes and face a rising incidence of retinal disorders such as diabetic retinopathy, glaucoma, and age-related macular degeneration. They use advanced imaging systems to ensure accurate diagnosis, effective treatment planning, and continuous disease monitoring. Skilled ophthalmologists, strong healthcare infrastructure, and integration with digital health systems further strengthen adoption. Hospitals also actively invest in fundus cameras for screening programs, research, and clinical trials, establishing themselves as the key end-users of high-end ophthalmic imaging equipment.

Fundus Camera Market Trends

• Rising prevalence of retinal disorders such as diabetic retinopathy, glaucoma, and age-related macular degeneration increases the need for early detection and detailed retinal imaging, driving demand for advanced fundus cameras. Globally, over 103 million people are affected by diabetic retinopathy, while around 76 million individuals live with glaucoma, significantly increasing diagnostic imaging demand.
• Growing adoption of AI-enabled and digital imaging systems enhances diagnostic accuracy, supports automated screening, and improves workflow efficiency in ophthalmic care settings. Studies show AI-assisted retinal screening can achieve over 90% sensitivity in detecting diabetic retinopathy, accelerating early diagnosis rates.
• Expanding use of tele-ophthalmology and remote screening programs strengthens access to eye care, particularly in underserved and rural regions, boosting demand for portable and connected fundus camera systems. More than 1 billion people globally have preventable or untreated vision impairment, highlighting the need for remote screening solutions.
• Increasing integration of fundus cameras with multimodal imaging systems such as OCT and fluorescein angiography improves clinical decision-making and expands use in complex ophthalmic diagnostics. Combined imaging approaches can improve diagnostic accuracy by up to 25–30% compared to standalone fundus imaging in complex retinal cases.

Regional Insights

North America dominates owing to Strong adoption of new technologies

North America is expected to dominate the fundus camera market with a 39.2% share in 2026, supported by strong adoption of advanced technologies. The region faces a high burden of retinal diseases, with more than 76 million people affected by glaucoma globally, a significant proportion of whom are in the U.S. and Canada, along with over 11 million Americans living with age-related macular degeneration (AMD). In addition, diabetic retinopathy impacts more than 9–10 million people in North America, driving consistent demand for retinal screening.

Advanced healthcare infrastructure, high per-capita healthcare spending (exceeding $12,000 per person annually in the U.S.), and strong reimbursement frameworks further support adoption. Widespread screening programs and preventive eye care initiatives contribute to early diagnosis rates, with over 60% of adults above 65 undergoing regular eye examinations. The growing elderly population, where nearly 20% of the U.S. population will be aged 65+ by 2030, further strengthens demand for advanced diagnostic imaging systems.

Asia Pacific Fundus Camera Market Trends

Rising prevalence of retinal disorders such as glaucoma, diabetic retinopathy, and age-related macular degeneration is driving the Asia Pacific fundus camera market by increasing the need for early diagnosis and large-scale screening. The region accounts for a significant share of the global diabetic population, with over 240 million people living with diabetes in Asia-Pacific, substantially raising the risk of diabetic retinopathy. Glaucoma also remains a major concern, affecting an estimated over 60% of the world’s glaucoma population in Asia, due to its large base of undiagnosed cases.

United States Fundus Camera Market Trends

Well-developed healthcare infrastructure, widespread adoption of AI-driven and digital imaging solutions, and strong ophthalmology networks continue to support market expansion. The U.S. is among the highest healthcare spending countries, with per-capita expenditure exceeding $12,000 annually, enabling rapid adoption of advanced diagnostic systems. The country also faces a significant disease burden, with over 11 million Americans affected by age-related macular degeneration (AMD) and more than 9 million living with diabetic retinopathy, driving continuous demand for retinal imaging.

Japan Fundus Camera Market Trends

The Japan fundus camera market expands due to a significant incidence of retinal disorders such as diabetic retinopathy, glaucoma, and age-related macular degeneration, which necessitate timely diagnosis and long-term monitoring. Japan’s rapidly aging society further accelerates the need for advanced retinal imaging solutions. The presence of a robust healthcare system, combined with strong integration of digital and AI-based diagnostic tools and mature ophthalmology services, reinforces market growth. In addition, government-led preventive screening initiatives and increasing hospital investments in advanced imaging technologies continue to boost demand for fundus cameras across the country.

Who are the Major Companies in Fundus Camera Industry

Some of the major key players in Fundus Camera are Carl Zeiss AG, Hoya Corporation, Canon Inc., Nidek Co., Ltd., Topcon Corporation, Intelligent Retinal Imaging Systems, Inc., Kowa Company Ltd., Optomed Oy (Ltd.), Vision Equipment Inc., Clarity Medical Systems, Inc., Medimaging Integrated Solution Inc., S4OPTIK LLC., Shenzhen Thondar Technology Co., Ltd., CenterVue SpA

Key News

• In August 2025, Optomed USA launched Optomed Lumo, a handheld fundus camera designed to enable high-quality retinal imaging in primary care and non-specialist healthcare settings beyond traditional ophthalmology and optometry clinics.

Market Report Scope

Analyst Opinion

• The fundus camera market is not expanding on speculation or incremental technological upgrades alone—it is being structurally pulled by the overwhelming and underdiagnosed global burden of retinal disease. More than 2.2 billion people globally suffer from vision impairment or blindness, and at least 1 billion of these cases are either preventable or remain untreated, according to global ophthalmic health estimates.
• Cataract and retinal complications together reinforce this demand at scale, with over 28 million cataract surgeries performed annually worldwide—translating to nearly 75,000 procedures every single day. While cataract itself is surgical, the pre- and post-operative workflows increasingly depend on retinal imaging to rule out comorbidities such as age-related macular degeneration and diabetic retinal damage.
• What is often underestimated is how aggressively retinal disease is intersecting with systemic lifestyle disorders. Diabetes alone continues to expand the at-risk population for diabetic retinopathy, and in clinical practice, fundus imaging has effectively become a mandatory screening gatekeeper before disease progression reaches irreversible stages.
• In essence, the market is being shaped less by technology push and more by disease pressure, surgical dependency, and systemic screening mandates. As retinal diseases continue to rise in prevalence and remain underdiagnosed in early stages, fundus cameras are transitioning into indispensable diagnostic infrastructure rather than optional imaging devices.

Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Mydriatic Fundus
  • Non-Retractable Fundus
  • Hybrid Fundus Cameras
  • Retinopathy of Prematurity (ROP) Fundus Cameras
• By Modality (Revenue, USD Bn, 2021-2033)
  • Stationary/Tabletop
  • Mobile
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Ophthalmology Clinics
  • Ophthalmic and Optometrist Offices
  • Others
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Carl Zeiss AG
  • Hoya Corporation
  • Canon Inc.
  • Nidek Co., Ltd.
  • Topcon Corporation
  • Intelligent Retinal Imaging Systems, Inc.
  • Kowa Company Ltd.
  • Optomed Oy (Ltd.)
  • Vision Equipment Inc.
  • Clarity Medical Systems, Inc.
  • Medimaging Integrated Solution Inc.
  • S4OPTIK LLC.
  • Shenzhen Thondar Technology Co., Ltd.
  • CenterVue SpA

Sources

Primary Research interviews

• Ophthalmologists and retinal specialists from hospitals and eye clinics
• Biomedical engineers and imaging device technicians
• Procurement managers from multispecialty hospitals
• Diagnostic imaging center administrators

Databases

• World Health Organization (WHO) Global Health Observatory
• National health databases (USA CDC, India MoHFW, Japan MHLW)
• PubMed Central and MEDLINE biomedical databases
• OECD Health Statistics
• World Bank Health Data

Magazines

• Ophthalmology Times
• EyeWorld Magazine
• Healthcare Technology Report
• Medical Device & Diagnostic Industry (MD+DI)

Journals

• Investigative Ophthalmology & Visual Science (IOVS)
• British Journal of Ophthalmology
• Journal of Ophthalmology
• Retina Journal
• Clinical Ophthalmology

Newspapers

• The Hindu
• The Times of India
• The New York Times (Health section)
• The Guardian (Health coverage)
• Nikkei Asia (Healthcare updates)

Associations

• American Academy of Ophthalmology (AAO)
• International Council of Ophthalmology (ICO)
• All India Ophthalmological Society (AIOS)
• World Council of Optometry (WCO)
• European Society of Retina Specialists (EURETINA)

Public Domain sources

• Government health ministry publications
• WHO reports and vision impairment datasets
• National blindness prevention program reports
• Open-access clinical trial registries
• University ophthalmology research publications

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 10 years